Top Markets
Coin of the day
BioLineRx Ltd. BioLineRx Ltd.

BioLineRx Ltd.

BLRX
Rank in Stocks #40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Share Price
$0.0048574
Market Cap
$126.82K
Change (1 day)
0.00%
Change (1 year)
-21.82%
Country
IL
Trade BioLineRx Ltd. (BLRX)

Category

Stock split history for BioLineRx Ltd. (BLRX)
BioLineRx Ltd. stock (symbol: BLRX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One BLRX share bought prior to Aug 13, 2026 would equal to 0 BLRX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE